key: cord-0788529-4fb63ysy
authors: Gao, Zhao-wei; Zhang, Hui-zhong; Liu, Chong; Dong, Ke
title: Autoantibodies in COVID-19: frequency and function
date: 2021-01-18
journal: Autoimmun Rev
DOI: 10.1016/j.autrev.2021.102754
sha: 7395e05f0cce09756a8c09ca5815c9166662f89c
doc_id: 788529
cord_uid: 4fb63ysy

nan

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. 

Covid-19 and autoimmunity

What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19? Autoimmun Rev

Covid-19 overlapping with systemic sclerosis

Clinical and Autoimmune Characteristics of Severe and Critical Cases of COVID-19

Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19

COVID-19 and immunological dysregulation: can autoantibodies be useful?

Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients

Lupus anticoagulant is frequent in patients with Covid-19

Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19

Prothrombotic antiphospholipid antibodies in COVID-19. medRxiv

Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases

Presence of antiphospholipid antibodies in COVID-19: case series study

Assessment of Lupus Anticoagulant Positivity in Patients With Coronavirus Disease 2019 (COVID-19)

Anticardiolipin IgG autoantibody level is an independent risk factor for COVID-19 severity. Arthritis Rheumatol

Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism

Auto-antibodies against type I IFNs in patients with life-threatening COVID-19

Cold agglutinin syndrome as a complication of Covid-19 in two cases